MStranslate logo
Log In
Lost your password?
Lost Password
Back to login
Search
  • HOME
  • Research
    • Basic Sciences
      • B Cells
    • Conferences
      • AAN
      • ACTRIMS
      • ECTRIMS
      • MS Virtual
    • COVID-19
    • Epstein-Barr virus
    • Genetics
    • Gut Microbiome
    • Hormones
    • Lifestyle
      • Diet
      • Exercise
      • Jelinek Group
      • Vitamin D
    • Medicinal Cannabis
    • Mental Health
    • Progressive MS
    • Remyelination
    • Stem Cells
    • Symptoms
      • Cognition
      • Fatigue
      • Quality of Life
      • Rehabilitation
  • Treatments
    • Alemtuzumab
    • Daclizumab
    • Dimethyl fumarate
    • Fingolimod
    • Interferon-Beta
    • Laquinimod
    • Natalizumab
    • Ocrelizumab
    • Clinical Trials & Studies
      • MIS416
  • Lifestyle
  • Collaborations
    • Dr Sally Shaw
    • Dr Travis Stiles
    • Employment & MS
    • Kriesel Lab
    • MBC@RMH
      • MSBase@MBC
      • PrevANZ
      • Neuroimaging
      • Basic Sciences
      • Ocular Motor
      • Movement Disorders & Rehabilitation
    • MitoQ
    • Multiple Sclerosis Limited
  • Connect
    • Live Research Q&A
  • About MStranslate
    • THE TEAM
    • THE APPROACH
    • VALUES & STANDARDS
  • Contact Us
Breaking
  • FDA Decision On Tolebrutinib
  • Multiple Sclerosis Research In 2026
  • Revisiting ECTRIMS Congress 2025
  • UPDATED: The ECTRIMS Podcast - Episode Library
  • Patient Community Day at ECTRIMS 2025
  • Multiple Sclerosis in 2025 – Key Developments to Date
  • HOME
  • Research
    • Basic Sciences
      • B Cells
    • Conferences
      • AAN
      • ACTRIMS
      • ECTRIMS
      • MS Virtual
    • COVID-19
    • Epstein-Barr virus
    • Genetics
    • Gut Microbiome
    • Hormones
    • Lifestyle
      • Diet
      • Exercise
      • Jelinek Group
      • Vitamin D
    • Medicinal Cannabis
    • Mental Health
    • Progressive MS
    • Remyelination
    • Stem Cells
    • Symptoms
      • Cognition
      • Fatigue
      • Quality of Life
      • Rehabilitation
  • Treatments
    • Alemtuzumab
    • Daclizumab
    • Dimethyl fumarate
    • Fingolimod
    • Interferon-Beta
    • Laquinimod
    • Natalizumab
    • Ocrelizumab
    • Clinical Trials & Studies
      • MIS416
  • Lifestyle
  • Collaborations
    • Dr Sally Shaw
    • Dr Travis Stiles
    • Employment & MS
    • Kriesel Lab
    • MBC@RMH
      • MSBase@MBC
      • PrevANZ
      • Neuroimaging
      • Basic Sciences
      • Ocular Motor
      • Movement Disorders & Rehabilitation
    • MitoQ
    • Multiple Sclerosis Limited
  • Connect
    • Live Research Q&A
  • About MStranslate
    • THE TEAM
    • THE APPROACH
    • VALUES & STANDARDS
  • Contact Us

Tagged Treatments

multiple sclerosis research

Emerging Themes in Multiple Sclerosis Research

MStranslate
November 5, 2019
Opinion, Research, Videos
On a recent visit to Melbourne, Australia, Prof Amit Bar-Or (University of Pennsylvania) sat down with Prof Trevor Kilpatrick (University of...
ECTRIMS 2019

ECTRIMS 2019: Final Thoughts From Stockholm

MStranslate
September 13, 2019
Dr Travis Stiles, ECTRIMS, Research
ECTRIMS 2019 has officially ended.  It is safe to say that it was a huge three days and I am exhausted!  I really hope that you have enjoyed the...
Mavenclad

FDA Approves Second Drug For Active SPMS

MStranslate
April 1, 2019
Research, Treatments
Late last week, it was announced that Mavenclad (cladribine) received US FDA approval for the treatment of adults living with relapsing multiple...
siponimod

New Treatment Approved for Active SPMS

MStranslate
March 27, 2019
Research, Treatments
1 Comment
It was announced earlier today that Mayzent (siponimod) has received US FDA approval for the treatment of adults living with relapsing multiple...
Cocoa

Does a Cocoa a Day Keep MS Fatigue Away?

MStranslate
March 19, 2019
Fatigue, Research, Symptoms, Treatments
1 Comment
Research Summary: A randomised double-blind placebo-controlled feasibility trial of flavonoid-rich cocoa for fatigue in people with relapsing and...
CORe Unit

MS Treatments Delay Progressive Disease

MStranslate
February 12, 2019
Progressive MS, Research, Treatments
Research Summary: Association of Initial Disease-Modifying With Later Conversion to Secondary Progressive Multiple Sclerosis In mid-January, we had...
treatment decision

What influences the choice of treatment in MS?

MStranslate
November 28, 2018
Research, Treatments, Uncategorized
Research Summary: Understanding treatment decisions from the perspective of people with relapsing remitting multiple sclerosis: A critical...
T Cell Therapy

EBV-Specific T Cell Therapy for Progressive MS

MStranslate
November 20, 2018
Epstein-Barr virus, Infection, Progressive MS, Research, Treatments
Research Summary: Epstein-Barr virus-specific T cell therapy for progressive multiple sclerosis Last week, during our Facebook Live Q&A, we...
Ocrevus

Ocrevus and PPMS: Where to from here?

MStranslate
September 10, 2018
Ocrelizumab, Opinion, Treatments
The following is an opinion piece written by MStranslate co-founder, Brett Drummond. Let’s rewind to last March last year…there is worldwide...
cannabis for chronic pain

Cannabis and Chronic Pain: Research Summary

MStranslate
July 19, 2018
Medicinal Cannabis, Research, Treatments
Research Summary: Effect of cannabis use in people with chronic non-cancer pain prescribed opioids: findings from a 4-year prospective cohort...
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6

Recent Posts

  • FDA Decision On Tolebrutinib
  • Multiple Sclerosis Research In 2026
  • Revisiting ECTRIMS Congress 2025
  • UPDATED: The ECTRIMS Podcast – Episode Library
  • Patient Community Day at ECTRIMS 2025

Recent Comments

  • FDA Decision On Tolebrutinib - MStranslate on Multiple Sclerosis in 2025 – Key Developments to Date
  • Treatment With Gut Bacteria Shows Benefits In New Study on Gut Bacteria in People Living with RRMS
  • Community Q&A: COVID-19 Vaccines & Multiple Sclerosis on Community Q&A: The Blood-Brain Barrier
  • Community Q&A: Why Don't We Have A Multiple Sclerosis Cure? on Community Q&A: COVID-19 Vaccines & MS
  • Tim Little on FAKE NEWS ALERT: COVID Vaccines & MS

Calendar

March 2026
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  
« Jan    

Archives

Categories

Posts

  • FDA Decision On Tolebrutinib
  • Multiple Sclerosis Research In 2026
  • Revisiting ECTRIMS Congress 2025
  • UPDATED: The ECTRIMS Podcast – Episode Library
  • Patient Community Day at ECTRIMS 2025

Google+

Get social

Copyright 2014-2018 MStranslate. All Rights Reserved. Contact Us
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.